Anavex Life Sciences Corporation (AVXL)

11:57 AM

How strong is Anavex Life Sciences Corp. stock revenue growthWeekly Investment Recap & Weekly High Conviction Ideas - newser.com

11:57 AM

10:58 AM

Detecting price anomalies in Anavex Life Sciences Corp. with AIJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com

10:58 AM

10:32 AM

Real time breakdown of Anavex Life Sciences Corp. stock performanceMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com

10:32 AM

08:31 AM

Can trapped investors hope for a rebound in Anavex Life Sciences Corp.July 2025 Sentiment & Long-Term Safe Investment Plans - newser.com

08:31 AM

07:57 AM

How Anavex Life Sciences Corp. stock valuations compare to rivalsJuly 2025 Update & AI Powered Market Entry Strategies - newser.com

07:57 AM

Oct 12, 2025

Heatmap analysis for Anavex Life Sciences Corp. and competitorsWeekly Stock Summary & Safe Entry Zone Identification - newser.com

Oct 12, 2025

Oct 10, 2025

Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’ - The Manila Times

Oct 10, 2025

Oct 10, 2025

Anavex Life Sciences Corp. Announces Oral Presentation on Alzheimer's Disease Care at Alzheimer Europe Conference - Quiver Quantitative

Oct 10, 2025

Oct 10, 2025

Oral Blarcamesine Presented at 35th Alzheimer Europe — Anavex Highlights ANAVEX®2-73-AD-004 IIb/III - Stock Titan

Oct 10, 2025

Oct 10, 2025

Will Anavex Life Sciences Corp. (12X1) stock keep high P E multiplesJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com

Oct 10, 2025

Oct 09, 2025

Is Anavex Life Sciences Corp. (12X1) stock testing key supportWeekly Trade Report & Community Verified Trade Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Anavex Life Sciences (NASDAQ:AVXL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 07, 2025

Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 07, 2025

Oct 07, 2025

HC Wainwright & Co. Reiterates Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq

Oct 07, 2025

Oct 07, 2025

Anavex Life Sciences stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Oct 07, 2025

Oct 06, 2025

How Anavex Life Sciences Corp. stock reacts to global recession fearsBreakout Watch & Low Drawdown Momentum Ideas - newser.com

Oct 06, 2025

Oct 05, 2025

Long term hold vs stop loss in Anavex Life Sciences Corp.Analyst Downgrade & Community Consensus Stock Picks - newser.com

Oct 05, 2025

Oct 05, 2025

Tools to monitor Anavex Life Sciences Corp. recovery probabilityEarnings Risk Report & Advanced Technical Signal Analysis - newser.com

Oct 05, 2025

Oct 03, 2025

Anavex Life Sciences (NASDAQ:AVXL) Trading Up 8.7%Should You Buy? - MarketBeat

Oct 03, 2025

Oct 03, 2025

Anavex Life Sciences (Nasdaq:AVXL) Reports Positive Phase 2 Results for ANAVEX®3-71 in Schizophrenia - Kalkine Media

Oct 03, 2025

Oct 02, 2025

D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq

Oct 02, 2025

Oct 02, 2025

Is Anavex Life Sciences Corp a good long term investmentBollinger Bands Signals & Free Phenomenal Capital Appreciation - earlytimes.in

Oct 02, 2025

Oct 02, 2025

Anavex: ANAVEX 3-71 Could Potentially Offer Disease-Modifying Effects For Schizophrenia - Seeking Alpha

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences (NASDAQ:AVXL) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences (AVXL): Analyst Reaffirms "Buy" Rating | AV - GuruFocus

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update - Stocktwits

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences (AVXL) Shares Rise on Positive Trial Result - GuruFocus

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences Reports Positive Phase 2 Results for ANAVEX®3-71 in Schizophrenia Clinical Study Achieving Safety and Tolerability Endpoints - Quiver Quantitative

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program - The Manila Times

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - The Manila Times

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences stock rises after positive schizophrenia drug trial - Investing.com

Oct 02, 2025

Oct 02, 2025

Anavex Develops Once-Daily Tablet for ANAVEX3-71 in Phase 1b Trial | AVXL Stock News - Stock Titan

Oct 02, 2025

Oct 02, 2025

Novel Schizophrenia Drug ANAVEX3-71 Shows Promise: Safe Profile and Reduced Brain Inflammation Markers - Stock Titan

Oct 02, 2025

Oct 02, 2025

Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World

Oct 02, 2025

Oct 01, 2025

Alzheimer’s Disease Market: Epidemiology, Therapies, and Key Players | Anavex Life Sciences Corp., TauRx Therapeutics Ltd, BioVie Inc., AriBio Co., Ltd., Novo Nordisk A/S, AgeneBio, Neurim Pharmaceuti - Barchart.com

Oct 01, 2025

Oct 01, 2025

Anavex Life Sciences (NASDAQ:AVXL) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Oct 01, 2025

Oct 01, 2025

Alzheimer's Disease Market: Epidemiology, Therapies, And Key Players Anavex Life Sciences Corp., Taurx Therapeutics Ltd, Biovie Inc., Aribio Co., Ltd., Novo Nordisk A/S, Agenebio, Neurim Pharmaceuti - Menafn.com

Oct 01, 2025

Oct 01, 2025

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial - markets.businessinsider.com

Oct 01, 2025

Sep 30, 2025

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer's Disease Trial - Investing News Network

Sep 30, 2025

Sep 30, 2025

Anavex Life Sciences Announces Publication of Oral - GlobeNewswire

Sep 30, 2025

Sep 30, 2025

70% Success Rate: Anavex's Once-Daily Oral Alzheimer's Drug Shows Breakthrough Results in Late-Stage Trial - Stock Titan

Sep 30, 2025

Sep 30, 2025

Why millennials buy Anavex Life Sciences Corp. (12X1) stockJuly 2025 PostEarnings & Daily Price Action Insights - newser.com

Sep 30, 2025

Sep 29, 2025

How to recover losses in Anavex Life Sciences Corp. stockJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com

Sep 29, 2025

Sep 29, 2025

Real time pattern detection on Anavex Life Sciences Corp. stockMarket Volume Summary & Target Return Focused Stock Picks - newser.com

Sep 29, 2025

Sep 28, 2025

What drives PRCT stock priceMarket Sentiment Shifts & These 3 Stocks Could Change Your Portfolio - earlytimes.in

Sep 28, 2025

Sep 28, 2025

What drives Anavex Life Sciences Corp stock priceOptions Trading Strategies & Minimal Capital Growth Plans - earlytimes.in

Sep 28, 2025

Sep 26, 2025

What analysts say about Anavex Life Sciences Corp stockEquity Performance Review & Stocks With 200% Upside Potential - Early Times

Sep 26, 2025

Sep 26, 2025

How Anavex Life Sciences Corp. (12X1) stock trades pre earningsJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com

Sep 26, 2025

Sep 24, 2025

H.C. Wainwright Reiterates Its ‘Buy’ Rating on Anavex Life Sciences Corp. (AVXL) with a $42 Price Target - Insider Monkey

Sep 24, 2025

Sep 22, 2025

Anavex Life Sciences Corp. $AVXL Shares Sold by Goldman Sachs Group Inc. - MarketBeat

Sep 22, 2025

Sep 22, 2025

Published on: 2025-09-22 05:58:42 - newser.com

Sep 22, 2025